Novo Nordisk is still worried about revenue growth next year despite obesity pill: BMO’s Seigerman
Evan Seigerman, BMO head of healthcare research, joins 'Power Lunch' to discuss Seigerman's thoughts on Novo Nordisk, its competitor Eli ...
Wednesday, March 4, 2026
Tag: Seigerman
BMO’s Seigerman on Pfizer-Metsera deal: Bullish as we’ve waited on Pfizer’s foray into obesity
Evan Seigerman, BMO Capital Markets head of healthcare research, joins 'The Exchange' to discuss Pfizer's obesity drug prospects, competitors and ...
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.